FDA approves GSK's drug for skin infection

The FDA approved GlaxoSmithKline's Altabax for treating the skin infection impetigo, caused by the staphylococcus and streptococcus bacteria. The drug is the first in a new class of prescription tropical antibacterial to be approved by FDA in almost 20 years. GSK also is seeking European approval of Altabax.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC